Article
Pharmacology & Pharmacy
Brandon W. Lewis, Maria L. Ford, Aiman Q. Khan, Joshua Walum, Rodney D. Britt
Summary: Type 2-high severe asthma is a distinct subtype characterized by Th2 inflammation, high eosinophil lung infiltration, impaired lung function, and reduced corticosteroid sensitivity. Acute and chronic allergen models induce type 2 inflammation, but the differences in corticosteroid sensitivity remain unclear. This study found that chronic allergen exposure is associated with more persistent type 2 immune responses and corticosteroid insensitivity.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Chemistry, Multidisciplinary
Chao Ye, Fen Zheng, Nan Wu, Guo-qing Zhu, Xiu-zhen Li
Summary: Vascular remodeling plays a crucial role in the development of various vascular diseases and is closely associated with the release of extracellular vesicles (EVs). EVs impact vascular remodeling by affecting oxidative stress, inflammation, calcification, and lipid plaque formation. Therefore, EVs have the potential to be used as biomarkers for diagnosis and prognosis, as well as therapeutic targets for vascular remodeling and cardiovascular diseases.
ACTA PHARMACOLOGICA SINICA
(2022)
Article
Pharmacology & Pharmacy
Wenxian Ma, Qiaoyan Jin, Haiqin Guo, Xinpeng Han, Lingbin Xu, Shemin Lu, Changgui Wu
Summary: This study demonstrates that metformin can alleviate airway inflammation and remodeling in an OVA-induced chronic asthmatic model. The protective effects of metformin may be associated with the restoration of AMPKα activity and decreased asthma-related angiogenesis.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Endocrinology & Metabolism
Nele Warmke, Fiona Platt, Alexander F. Bruns, Claire H. Ozber, Natalie J. Haywood, Yilizila Abudushalamu, Charles Slater, Victoria Palin, Piruthivi Sukumar, Stephen B. Wheatcroft, Nadira Y. Yuldasheva, Mark T. Kearney, Kathryn J. Griffin, Richard M. Cubbon
Summary: In this study, pericyte insulin signaling was found to promote angiopoietin-1 secretion and endothelial Tie2 signaling. Disruption of this pathway led to excessive vascular sprouting and venous plexus abnormalities, mimicking diabetic retinopathy characteristics. Future research should focus on evaluating the role of pericyte insulin signaling in this disease.
Article
Endocrinology & Metabolism
Nele Warmke, Fiona Platt, Alexander F. Bruns, Claire H. Ozber, Natalie J. Haywood, Yilizila Abudushalamu, Charles Slater, Victoria Palin, Piruthivi Sukumar, Stephen B. Wheatcroft, Nadira Y. Yuldasheva, Mark T. Kearney, Kathryn J. Griffin, Richard M. Cubbon
Summary: Pericytes play a crucial role in regulating vascular development and stability, with dysfunction potentially contributing to diabetic retinopathy. Knockout of insulin receptors in pericytes resulted in abnormal vascular development, indicating the importance of insulin signaling in promoting angiopoietin-1 secretion and endothelial Tie2 signaling.
Review
Pharmacology & Pharmacy
Bo-wen Zhou, Hua-man Liu, Xin-hua Jia
Summary: Asthma as an individual disease remains a global health challenge. Traditional Chinese Medicine (TCM) has been shown to have anti-asthma effects, but its specific role and mechanism are still unclear. Animal studies have demonstrated that TCM formulas and natural compounds can significantly alleviate airway structural alterations and exhibit anti-inflammatory effects.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Oncology
Emmi Kapiainen, Minna K. Kihlstrom, Riikka Pietila, Mika Kaakinen, Veli-Pekka Ronkainen, Hongmin Tu, Anne Heikkinen, Raman Devarajan, Ilkka Miinalainen, Anna Laitakari, Mohammadhassan Ansarizadeh, Qin Zhang, Gong-Hong Wei, Lloyd Ruddock, Taina Pihlajaniemi, Harri Elamaa, Lauri Eklund
Summary: The study investigates the role of different forms of ANGPT2 in cancer, revealing that ANGPT2(443) plays a crucial role in vascular remodeling, tumor growth, and metastasis.
Article
Oncology
Qin Yang, Qing Miao, Hui Chen, Duo Li, Yongfeng Luo, Joanne Chiu, Hong-Jun Wang, Michael Chuvanjyan, Michael S. Parmacek, Wei Shi
Summary: Abnormal growth of airway smooth muscle cells is a key feature in asthmatic airway remodeling. The role of Myocd, a transcriptional coactivator, in this process has been investigated in a mouse model of chronic asthma. Deletion of Myocd mitigated airway smooth muscle cell hypertrophy and hyperplasia, reduced inflammation and collagen deposition, and attenuated abnormal mucin production. Myocd could be a potential therapeutic target for treating severe and persistent asthma.
JOURNAL OF PATHOLOGY
(2023)
Article
Cell Biology
Shushi Huang, Shengban You, Jinfu Qian, Chengyi Dai, Siyuan Shen, Jun Wang, Weijian Huang, Guang Liang, Gaojun Wu
Summary: The study revealed the significant role of MD2 in Ang II-induced vascular remodeling, with its deficiency being able to suppress vascular fibrosis and VSMC phenotypic switching. This indicates that MD2 could be a potential therapeutic target for cardiovascular diseases.
Article
Cardiac & Cardiovascular Systems
Alberto Canfran-Duque, Noemi Rotllan, Xinbo Zhang, Irene Andres-Blasco, Bonne M. Thompson, Jonathan Sun, Nathan L. Price, Marta Fernandez-Fuertes, Joseph W. Fowler, Diego Gomez-Coronado, William C. Sessa, Chiara Giannarelli, Robert J. Schneider, George Tellides, Jeffrey G. McDonald, Carlos Fernandez-Hernando, Yajaira Suarez
Summary: The accumulation of 25-hydroxycholesterol (25-HC) in human coronary atherosclerotic lesions accelerates atherosclerosis progression and promotes plaque instability through autocrine and paracrine actions. Macrophage-derived 25-HC intensifies the inflammatory response of lipid-loaded macrophages and inhibits smooth muscle cell migration within the plaque. These effects are independent of 25-HC-mediated modulation of transcriptional activity.
Article
Oncology
Anna M. W. ten Voorde, Annemijn P. A. Wierenga, Rogier J. Nell, Pieter A. van der Velden, Gregorius P. M. Luyten, Robert M. Verdijk, Martine J. Jager
Summary: In uveal melanoma, ANG-2 is identified as an important prognostic factor, with high expression associated with high-risk tumors and metastasis development, making it a potential therapeutic target.
Review
Biology
Harshita Shailesh, Ibrahim A. Janahi
Summary: Obesity is a significant risk factor for asthma and has a detrimental effect on the severity of the disease. It impairs lung airway function and leads to increased inflammation and severe remodeling of the bronchus. This review discusses the current research on the role of obesity in modulating airway cell functions and explores different therapeutic approaches for treating obese asthmatic individuals.
Review
Immunology
Ning Zhang, Jing Xu, Congshan Jiang, Shemin Lu
Summary: This review explores the neural regulation mechanisms in the occurrence of allergic asthma, covering aspects from immune response, airway remodeling to pulmonary neuroendocrine cells. Although research in this area is still limited, further investigation into neural regulation can help us better understand the mechanism of asthma comprehensively, and find more effective ways to prevent and control asthma.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Plant Sciences
Ibrahim Sulaiman, Emmanuel Oshiogwe Okwuofu, Norhafizah Mohtarrudin, Jonathan Chee Woei Lim, Johnson Stanslas
Summary: The standardized Andrographis paniculata 50% ethanol extract (APEE50) showed anti-inflammatory effects in a mouse asthma model by down-regulating Th2 cytokine gene expression and oxidative stress levels.
JOURNAL OF ETHNOPHARMACOLOGY
(2024)
Article
Oncology
Ha -Ram Park, Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee, Alessandra Leong, Subrata Chowdhury, Carrie Shawber, Richard Carvajal, Gavin Thurston, Joon-Yong An, Amanda W. Lund, Hee Won Yang, Minah Kim
Summary: The position of T-cells in the tumor microenvironment affects their ability to encounter the tumor and kill it. The vascular destabilizing factor ANGPT2 causes vascular integrity issues in the tumor periphery, leading to a lack of T-cell infiltration in the tumor core, which is associated with a poor response to immunotherapy.
Article
Biochemistry & Molecular Biology
Courtney M. Williams, Jessica Harper Calderon, E. Hock, Yasalp Jimenez, Kevin Barringer, Marisa Carbonaro, Maria del Pilar Molina-Portela, Gavin Thurston, Zhe Li, Christopher Daly
Summary: Human Fibroblast Growth Factor 19 (FGF19) and mouse ortholog Fgf15 exhibit similar roles in liver regeneration and metabolism through the activation of Fgfr4/b-klotho (Klb). FGF19 has stronger effects on glucose and fatty acid metabolism compared to Fgf15, and only FGF19 can induce hepatocellular carcinoma (HCC). However, inhibiting FGF19/FGFR4 signaling in HCC patients may lead to toxicity from elevated bile acid levels.
Article
Hematology
David J. DiLillo, Kara Olson, Katja Mohrs, Thomas Craig Meagher, Kevin Bray, Olga Sineshchekova, Thomas Startz, Jessica Kuhnert, Marc W. Retter, Stephen Godin, Prachi Sharma, Frank Delfino, John Lin, Eric Smith, Gavin Thurston, Jessica R. Kirshner
Summary: CD3-engaging bispecific antibodies and CAR T cells are effective therapeutic approaches for treating tumors by redirecting T cells. A fully human bispecific antibody (REGN5458) was introduced, showing potent antitumor activities against MM. In comparison to anti-BCMA CAR T cells, this bsAb demonstrated rapid clearance of MM tumors in animal models, suggesting differences in therapeutic mechanisms.
Article
Oncology
Alexander J. Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Martin Kaatz, Karl D. Lewis, Nicole Basset-Seguin, Anne Lynn S. Chang, Stephane Dalle, Almudena Fernandez Orland, Lisa Licitra, Caroline Robert, Claas Ulrich, Axel Hauschild, Michael R. Migden, Reinhard Dummer, Siyu Li, Suk-Young Yoo, Kosalai Mohan, Ebony Coates, Vladimir Jankovic, Nathalie Fiaschi, Emmanuel Okoye, Ioannis D. Bassukas, Carmen Loquai, Vincenzo De Giorgi, Zeynep Eroglu, Ralf Gutzmer, Jens Ulrich, Susana Puig, Frank Seebach, Gavin Thurston, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Timothy Bowler, Matthew G. Fury
Summary: In patients resistant to anti-PD-(L)1, ipilimumab plus anti-PD-1 showed higher efficacy compared to ipilimumab monotherapy, with a higher objective response rate, longer progression-free survival, and longer overall survival, while maintaining a similar rate of grade 3-5 toxicity.
Article
Multidisciplinary Sciences
Wen Zhang, Peter G. Hawkins, Jing He, Namita T. Gupta, Jinrui Liu, Gabrielle Choonoo, Se W. Jeong, Calvin R. Chen, Ankur Dhanik, Myles Dillon, Raquel Deering, Lynn E. Macdonald, Gavin Thurston, Gurinder S. Atwal
Summary: This study introduces a computational framework with a novel method ICON for identifying reliable TCR-pMHC interactions and a neural network-based classifier TCRAI for predicting TCR-antigen specificity, which outperforms other state-of-the-art methods. The combination of ICON and TCRAI enables the discovery of novel subgroups of TCRs binding to a given pMHC via different mechanisms, facilitating the identification and understanding of TCR-antigen-specific interactions for basic immunological research and clinical immune monitoring.
Article
Oncology
John O. DaSilva, Katie Yang, Oliver Surriga, Thomas Nittoli, Arthur Kunz, Matthew C. Franklin, Frank J. Delfino, Shu Mao, Feng Zhao, Jason T. Giurleo, Marcus P. Kelly, Sosina Makonnen, Carlos Hickey, Pamela Krueger, Randi Foster, Zhaoyuan Chen, Marc W. Retter, Rabih Slim, Tara M. Young, William C. Olson, Gavin Thurston, Christopher Daly
Summary: Lung cancers with MET genetic alterations respond well to MET-selective inhibitors, but a small percentage of patients benefit and acquired resistance is a limitation. An ADC targeting MET shows potential for effective treatment of MET-overexpressing tumors that do not respond to current therapies. Preclinical studies demonstrate that METxMET-M114 induces substantial and durable tumor regression, indicating promise as a candidate for MET-overexpressing tumor treatment.
MOLECULAR CANCER THERAPEUTICS
(2021)
Article
Multidisciplinary Sciences
Lauric Haber, Kara Olson, Marcus P. Kelly, Alison Crawford, David J. DiLillo, Richard Tavare, Erica Ullman, Shu Mao, Lauren Canova, Olga Sineshchekova, Jennifer Finney, Arpita Pawashe, Supriya Patel, Ryan McKay, Sahar Rizvi, Ermelinda Damko, Danica Chiu, Kristin Vazzana, Priyanka Ram, Katja Mohrs, Amanda D'Orvilliers, Jenny Xiao, Sosina Makonnen, Carlos Hickey, Cody Arnold, Jason Giurleo, Ya Ping Chen, Courtney Thwaites, Drew Dudgeon, Kevin Bray, Ashique Rafique, Tammy Huang, Frank Delfino, Aynur Hermann, Jessica R. Kirshner, Marc W. Retter, Robert Babb, Douglas MacDonald, Gang Chen, William C. Olson, Gavin Thurston, Samuel Davis, John C. Lin, Eric Smith
Summary: By altering the binding affinity for CD3 alone, researchers can generate bispecific antibodies that maintain potent killing of TSA+tumor cells but display differential patterns of cytokine release, pharmacokinetics, and biodistribution, thus improving the therapeutic index of T-cell-engaging bispecific antibodies.
SCIENTIFIC REPORTS
(2021)
Article
Oncology
Andrew M. Leader, John A. Grout, Barbara B. Maier, Barzin Y. Nabet, Matthew D. Park, Alexandra Tabachnikova, Christie Chang, Laura Walker, Alona Lansky, Jessica Le Berichel, Leanna Troncoso, Nausicaa Malissen, Melanie Davila, Jerome C. Martin, Giuliana Magri, Kevin Tuballes, Zhen Zhao, Francesca Petralia, Robert Samstein, Natalie Roy D'Amore, Gavin Thurston, Alice O. Kamphorst, Andrea Wolf, Raja Flores, Pei Wang, Soren Muller, Ira Mellman, Mary Beth Beasley, Helene Salmon, Adeeb H. Rahman, Thomas U. Marron, Ephraim Kenigsberg, Miriam Merad
Summary: This study identified a cellular module called lung cancer activation module (LCAM(hi)) in early-stage NSCLC lesions, which consists of activated T cells, plasma cells, and macrophages, and is associated with enhanced response to immunotherapy. LCAM presence was found to be independent of overall immune cell content and correlated with TMB, cancer testis antigens, and TP53 mutations, suggesting it may serve as a nonredundant biomarker for immunotherapy response in NSCLC patients.
Article
Gastroenterology & Hepatology
Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon, Nathalie Fiaschi, Edward Kim, Stephen C. Ward, Zhen Zhao, Joel Kim, Paul Kennedy, Ganesh Gunasekaran, Parissa Tabrizian, Deborah Doroshow, Meredith Legg, Ashley Hammad, Assaf Magen, Alice O. Kamphorst, Muhammed Shareef, Namita T. Gupta, Raquel Deering, Wei Wang, Fang Wang, Pradeep Thanigaimani, Jayakumar Mani, Leanna Troncoso, Alexandra Tabachnikova, Christie Chang, Guray Akturk, Mark Buckup, Steven Hamel, Giorgio Ioannou, Clotilde Hennequin, Hajra Jamal, Haley Brown, Antoinette Bonaccorso, Daniel Labow, Umut Sarpel, Talia Rosenbloom, Max W. Sung, Baijun Kou, Siyu Li, Vladimir Jankovic, Nicola James, Sara C. Ham, Hung Kam Cheung, Jennifer S. Sims, Elizabeth Miller, Nina Bhardwaj, Gavin Thurston, Israel Lowy, Sacha Gnjatic, Bachir Tauli, Myron E. Schwartz, Miriam Merad
Summary: This study evaluated the clinical activity of neoadjuvant cemiplimab in patients with resectable hepatocellular carcinoma. The results showed that treatment with cemiplimab resulted in significant tumor necrosis and partial response in some patients. Adverse events were common but severe adverse events were rare. These findings contribute to further understanding the clinical benefit of preoperative PD-1 blockade in patients with hepatocellular carcinoma.
LANCET GASTROENTEROLOGY & HEPATOLOGY
(2022)
Article
Hematology
Matt Weinstock, Pavania Elavalakanar, Susan Bright, Srikanth R. Ambati, Jurriaan Brouwer-Visser, Stephane Pourpe, Nathalie Fiaschi, Vladimir Jankovic, Gavin Thurston, Raquel P. Deering, Aafia Chaudhry, Robin Joyce, Jon Arnason
Summary: CAR-T cell therapy has limited efficacy for patients with relapsed/refractory B-cell non-Hodgkin lymphoma. However, treatment with Odronextamab in these patients has shown durable and manageable responses.
BRITISH JOURNAL OF HAEMATOLOGY
(2022)
Article
Multidisciplinary Sciences
Marisa Carbonaro, Jeffrey Lee, Evangelos Pefanis, Mathieu Desclaux, Kehui Wang, Alexander Pennington, Hui Huang, Alejo Mujica, Jose Rojas, Roxanne Ally, Daniel Kennedy, Michael Brown, Vitaliy Rogulin, Sven Moller-Tank, Leah Sabin, Brian Zambrowicz, Gavin Thurston, Zhe Li
Summary: Humanized liver rodent models, an important tool in drug development and disease research, have been increasingly used. Researchers have successfully generated a rat model similar to humanized liver mice and developed new methods for studying liver disease and hepatocyte-targeted therapies.
SCIENTIFIC REPORTS
(2022)
Article
Multidisciplinary Sciences
Michael D. Kessler, Amy Damask, Sean O'Keeffe, Nilanjana Banerjee, Dadong Li, Kyoko Watanabe, Anthony Marketta, Michael Van Meter, Stefan Semrau, Julie Horowitz, Jing Tang, Jack A. Kosmicki, Veera M. Rajagopal, Yuxin Zou, Yariv Houvras, Arkopravo Ghosh, Christopher Gillies, Joelle Mbatchou, Ryan R. White, Niek Verweij, Jonas Bovijn, Neelroop N. Parikshak, Michelle G. LeBlanc, Marcus Jones, David J. Glass, Luca A. Lotta, Michael N. Cantor, Gurinder S. Atwal, Adam E. Locke, Manuel A. R. Ferreira, Raquel Deering, Charles Paulding, Alan R. Shuldiner, Gavin Thurston, Adolfo A. Ferrando, Will Salerno, Jeffrey G. Reid, John D. Overton, Jonathan Marchini, Hyun M. Kang, Aris Baras, Goncalo R. Abecasis, Eric Jorgenson
Summary: Clonal haematopoiesis, associated with ageing and adverse health outcomes, involves the expansion of certain blood cell lineages. This study identified novel germline genetic variations influencing predisposition to clonal haematopoiesis using exome sequence data from over 600,000 individuals. The study also found associations between clonal haematopoiesis and severe COVID-19 outcomes, cardiovascular disease, and malignancy.
Article
Cell Biology
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu, Amanda Krasco, Kara Olson, Sahar Rizvi, Nathalie Fiaschi, Sandra Coetzee, Fang Wang, Erica Ullman, Hassan Shakil Ahmed, Evan Herlihy, Ken Lee, Lauren Havel, Terra Potocky, Sarah Ebstein, Davor Frleta, Aditi Khatri, Stephen Godin, Sara Hamon, Jurriaan Brouwer-Visser, Travis Gorenc, Doug MacDonald, Aynur Hermann, Aafia Chaudhry, Andres Sirulnik, William Olson, John Lin, Gavin Thurston, Israel Lowy, Andrew J. Murphy, Eric Smith, Vladimir Jankovic, Matthew A. Sleeman, Dimitris Skokos
Summary: The combination of odronextamab and REGN5837 could provide a chemotherapy-free approach for the treatment of DLBCL, as REGN5837 enhances the antitumor activity of odronextamab by potentiating T cell activation and cytolytic function. Preclinical studies have shown promising results, and the presence of a population of CD28+CD8+ T cells after odronextamab treatment suggests potential targeting by REGN5837.
SCIENCE TRANSLATIONAL MEDICINE
(2022)
Article
Oncology
Richard Tavare, Makenzie Danton, Jason T. Giurleo, Sosina Makonnen, Carlos Hickey, Tomas C. Arnold, Marcus P. Kelly, Fanny Fredriksson, Karina Bruestle, Aynur Hermann, Erica Ullman, Kurt H. Edelmann, Terra Potocky, Drew Dudgeon, Nikunj B. Bhatt, Mikhail Doubrovin, Thomas Barry, Christos A. Kyratsous, Cagan Gurer, Naxin Tu, Hans Gartner, Andrew Murphy, Lynn E. Macdonald, Jon Popke, Akiva Mintz, Adam Griesemer, William C. Olson, Gavin Thurston, Dangshe Ma, Jessica R. Kirshner
Summary: Assessment of immune-cell subsets within the tumor immune microenvironment using immuno-positron emission tomography (PET) is a promising approach. This study developed 89Zr-DFO-REGN5054 to monitor CD8 thorn tumor-infiltrating lymphocytes (TIL) and demonstrated minimal impact on T-cell activity. Preclinical immuno-PET studies and toxicology studies in monkeys showed specific targeting to lymphoid tissues and no overt toxicity.
CANCER IMMUNOLOGY RESEARCH
(2022)
Letter
Gastroenterology & Hepatology
Thomas U. Marron, Myron E. Schwartz, Elizabeth Miller, Pradeep Thanigaimani, Israel Lowy, Gavin Thurston, Miriam Merad
LANCET GASTROENTEROLOGY & HEPATOLOGY
(2022)
Article
Oncology
Nikos Kourtis, Qingqing Wang, Bei Wang, Erin Oswald, Christina Adler, Samvitha Cherravuru, Evangelia Malahias, Lance Zhang, Jacquelynn Golubov, Qiaozhi Wei, Samantha Lemus, Min Ni, Yueming Ding, Yi Wei, Gurinder S. Atwal, Gavin Thurston, Lynn E. Macdonald, Andrew J. Murphy, Ankur Dhanik, Matthew A. Sleeman, Scott S. Tykodi, Dimitris Skokos
Summary: This study maps the chromatin landscape of immune cells in patients with early-stage clear cell renal cell carcinoma (ccRCC) and identifies the association between NF-kappa B and dysfunction in CD8(+) T cells. Importantly, it provides a valuable resource for understanding the functional states and regulatory dynamics of immune cells in ccRCC.